Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03657043 |
Title | A Study of Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With a Safety Run-in of a Dose-Dense Regimen (innovaTV 208) |
Recruitment | Completed |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Seattle Genetics, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | IRL | ESP | DNK | BEL |